167 related articles for article (PubMed ID: 38615059)
21. Lower TSH and higher free thyroxine predict incidence of prostate but not breast, colorectal or lung cancer.
Chan YX; Knuiman MW; Divitini ML; Brown SJ; Walsh J; Yeap BB
Eur J Endocrinol; 2017 Oct; 177(4):297-308. PubMed ID: 28684452
[TBL] [Abstract][Full Text] [Related]
22. Investigation on potential associations of oxidatively generated DNA/RNA damage with lung, colorectal, breast, prostate and total cancer incidence.
Gào X; Holleczek B; Cuk K; Zhang Y; Anusruti A; Xuan Y; Xu Y; Brenner H; Schöttker B
Sci Rep; 2019 May; 9(1):7109. PubMed ID: 31068619
[TBL] [Abstract][Full Text] [Related]
23. Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer.
Edwards BK; Noone AM; Mariotto AB; Simard EP; Boscoe FP; Henley SJ; Jemal A; Cho H; Anderson RN; Kohler BA; Eheman CR; Ward EM
Cancer; 2014 May; 120(9):1290-314. PubMed ID: 24343171
[TBL] [Abstract][Full Text] [Related]
24. Estimates of cancer burden in Campania.
Fusco M; De Angelis R; Senatore G; Zigon G; Rossi S
Tumori; 2013; 99(3):374-81. PubMed ID: 24158067
[TBL] [Abstract][Full Text] [Related]
25. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
Elife; 2023 Mar; 12():. PubMed ID: 36971353
[TBL] [Abstract][Full Text] [Related]
26. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
27. Expected years of life lost for six potentially preventable cancers in the United States.
Liu PH; Wang JD; Keating NL
Prev Med; 2013 May; 56(5):309-13. PubMed ID: 23428566
[TBL] [Abstract][Full Text] [Related]
28. Italian cancer burden by broad geographical area.
Baili P; De Angelis R; Casella I; Grande E; Inghelmann R; Francisci S; Verdecchia A; Capocaccia R; Meneghini E; Micheli A
Tumori; 2007; 93(4):398-407. PubMed ID: 17899872
[TBL] [Abstract][Full Text] [Related]
29. [Risk factors of main cancer sites].
Uleckiene S; Didziapetriene J; Griciūte LL; Urbeliene J; Kasiulevicius V; Sapoka V
Medicina (Kaunas); 2008; 44(12):989-95. PubMed ID: 19142058
[TBL] [Abstract][Full Text] [Related]
30. Estimates of cancer burden in Abruzzo and Molise.
Foschi R; Viviano L; Rossi S
Tumori; 2013; 99(3):366-73. PubMed ID: 24158066
[TBL] [Abstract][Full Text] [Related]
31. Age- and time-dependent changes in cancer incidence among immigrants to Sweden: colorectal, lung, breast and prostate cancers.
Mousavi SM; Fallah M; Sundquist K; Hemminki K
Int J Cancer; 2012 Jul; 131(2):E122-8. PubMed ID: 22052616
[TBL] [Abstract][Full Text] [Related]
32. Population Attributable Fraction of Established Modifiable Risk Factors on Colorectal Cancer in Korea.
Cho S; Shin A
Cancer Res Treat; 2021 Apr; 53(2):480-486. PubMed ID: 33070559
[TBL] [Abstract][Full Text] [Related]
33. Intake of flavonoids and risk of cancer in Finnish men: The Kuopio Ischaemic Heart Disease Risk Factor Study.
Mursu J; Nurmi T; Tuomainen TP; Salonen JT; Pukkala E; Voutilainen S
Int J Cancer; 2008 Aug; 123(3):660-3. PubMed ID: 18338754
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology of cancer in the United States.
Cresanta JL
Prim Care; 1992 Sep; 19(3):419-41. PubMed ID: 1410056
[TBL] [Abstract][Full Text] [Related]
35. Estimates of cancer burden in Sicily.
Tumino R; Capocaccia R; Traina A; Madeddu A; Contrino ML; Zigon G
Tumori; 2013; 99(3):399-407. PubMed ID: 24158070
[TBL] [Abstract][Full Text] [Related]
36. [Preventability estimates for colorectal and breast cancer in Germany. A methodological evaluation of the risk factors alcohol and overweight].
Wienecke A; Knorpp L; Stegmüller K; Kroke A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Mar; 56(3):439-46. PubMed ID: 23322150
[TBL] [Abstract][Full Text] [Related]
37. Urinary 8-isoprostane levels and occurrence of lung, colorectal, prostate, breast and overall cancer: Results from a large, population-based cohort study with 14 years of follow-up.
Gào X; Brenner H; Holleczek B; Cuk K; Zhang Y; Anusruti A; Xuan Y; Xu Y; Schöttker B
Free Radic Biol Med; 2018 Aug; 123():20-26. PubMed ID: 29778463
[TBL] [Abstract][Full Text] [Related]
38. Estimates of cancer burden in Tuscany.
Ventura L; Miccinesi G; Buzzoni C; Crocetti E; Paci E; Foschi R; Rossi S
Tumori; 2013; 99(3):334-41. PubMed ID: 24158062
[TBL] [Abstract][Full Text] [Related]
39. Prospective investigation of body mass index, colorectal adenoma, and colorectal cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
Kitahara CM; Berndt SI; de González AB; Coleman HG; Schoen RE; Hayes RB; Huang WY
J Clin Oncol; 2013 Jul; 31(19):2450-9. PubMed ID: 23715565
[TBL] [Abstract][Full Text] [Related]
40. Estimates of cancer burden in Marche.
Tavilla A; Vitarelli S; Rossi S; Foschi R
Tumori; 2013; 99(3):351-8. PubMed ID: 24158064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
